Respiratory Assist Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4000
Buy Report Download FREE Resources

Published: July 25, 2024 Report Code: GDME1795EPD-ST

Select Item

Respiratory Assist Devices Pipeline Market Report Overview

Respiratory assist devices facilitate breathing during respiratory failure and other respiratory disease conditions.

The respiratory assist devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Segment ·       Artificial Lung

·       Respiratory Assist Catheter
Key Territories ·       The United States

·       Europe

·       India

·       Israel

·       Brazil
Key Regulatory Paths ·       510(k)

·       PMA

·       CE
Leading Companies ·       Airiver Medical Inc

·       ALung Technologies Inc

·       Baxter Healthcare Corp

·       Belluscura Plc

·       Braile Biomedica Ltda
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

 Buy the Full Report for More Insights into the Respiratory Assist Devices Pipeline Market

Download a Free Report Sample

Respiratory Assist Devices Pipeline Market Segments

The key segments in the respiratory assist devices market are artificial lung and respiratory assist catheters. As of July 2024, the artificial lung segment accounted for the highest number of pipeline products.

Respiratory Assist Devices Pipeline Market Analysis by Segments, 2024 (%)

Respiratory Assist Devices Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Segment Insights into the Respiratory Assist Devices Pipeline Market

Download a Free Report Sample

Respiratory Assist Devices Pipeline Market Segmentation by Territories

The United States (US), Europe, India, Israel, and Brazil among others are a few of the key territories of the respiratory assist devices pipeline market. As of July 2024, the US accounted for the highest number of pipeline products.

Respiratory Assist Devices Pipeline Market Analysis by Territories, 2024 (%)

Respiratory Assist Devices Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Respiratory Assist Devices Pipeline Market

Download a Free Report Sample

Respiratory Assist Devices Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the respiratory assist devices pipeline products market are 510(k), PMA, and CE. As of July 2024, 510(k) was the most followed pathway for pipeline products in the respiratory assist devices market.

Respiratory Assist Devices Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Respiratory Assist Devices Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Respiratory Assist Devices Pipeline Market

Download a Free Report Sample

Respiratory Assist Devices Pipeline Market – Competitive Landscape

A few of the key companies associated with the respiratory assist devices pipeline market are Airiver Medical Inc, ALung Technologies Inc, Baxter Healthcare Corp, Belluscura Plc, and Braile Biomedica Ltda, among others.

Baxter Healthcare Corp: Baxter Healthcare Corp (Baxter Healthcare) is a pharmaceutical company that delivers products and services that are essential building blocks of healthcare. The company develops, manufactures, and markets healthcare equipment and instruments for the treatment of hemophilia, kidney disease, trauma, immune disorders, infectious diseases, and chronic and acute medical conditions.

Respiratory Assist Devices Pipeline Market Analysis by Companies, 2024
Respiratory Assist Devices Pipeline Market Analysis by Companies, 2024Buy the Full Report for More Company Insights into the Respiratory Assist Devices Pipeline Market
Download a Free Report Sample

Segments Covered in the Report

Respiratory Assist Devices Pipeline Market Segments Outlook (2024)

  • Artificial Lung
  • Respiratory Assist Catheter

Respiratory Assist Devices Pipeline Market Territories Outlook (2024)

  • The United States
  • Europe
  • India
  • Israel
  • Brazil

Respiratory Assist Devices Pipeline Market Regulatory Paths Outlook (2024)

  • 510(k)
  • PMA
  • CE

Scope

This report provides:

  • Extensive coverage of the respiratory assist devices under development.

  • Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.

  • Reviews of major players involved in the development of respiratory assist devices and lists all their pipeline projects.

  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.

  • Key clinical trial data of ongoing clinical trials specific to pipeline products.

  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.

  • Identify and understand important and diverse types of respiratory assist devices under development.

  • Develop market-entry and market-expansion strategies.

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Advanced Respiratory Technologies LLC
Airiver Medical Inc
ALung Technologies Inc
Baxter Healthcare Corp
Belluscura Plc
Braile Biomedica Ltda
Case Western Reserve University
Collplant Biotechnologies Ltd
enmodes GmbH
Liberate Medical LLC
Lung Biotechnology PBC
Maquet Cardiopulmonary GmbH
McGowan Institute for Regenerative Medicine
Michigan Critical Care Consultants Inc
Minnesota Health Solutions Corporation
Miromatrix Medical Inc
Postgraduate Institute of Medical Education and Research
Rice University
The Charles Stark Draper Laboratory Inc
TVS Group
U.S. Ann Arbor Healthcare System
University of Arizona
University of California Los Angeles
University of Michigan
University of Minnesota
University of Pittsburgh
Veterans Health Administration
X-COR Therapeutics
Xenios AG

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 8

2 Introduction 9

2.1 Respiratory Assist Devices Overview 9

3 Products under Development 10

3.1 Respiratory Assist Devices – Pipeline Products by Stage of Development 10

3.2 Respiratory Assist Devices – Pipeline Products by Segment 11

3.3 Respiratory Assist Devices – Pipeline Products by Territory 12

3.4 Respiratory Assist Devices – Pipeline Products by Regulatory Path 13

3.5 Respiratory Assist Devices – Pipeline Products by Estimated Approval Date 14

3.6 Respiratory Assist Devices – Ongoing Clinical Trials 15

4 Respiratory Assist Devices – Pipeline Products under Development by Companies 16

4.1 Respiratory Assist Devices Companies – Pipeline Products by Stage of Development 16

4.2 Respiratory Assist Devices – Pipeline Products by Stage of Development 18

5 Respiratory Assist Devices Companies and Product Overview 20

5.1 Advanced Respiratory Technologies LLC Company Overview 20

5.1.1 Advanced Respiratory Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 20

5.2 Airiver Medical Inc Company Overview 21

5.2.1 Airiver Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 21

5.3 ALung Technologies Inc Company Overview 26

5.3.1 ALung Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 26

5.4 Baxter Healthcare Corp Company Overview 30

5.4.1 Baxter Healthcare Corp Pipeline Products & Ongoing Clinical Trials Overview 30

5.5 Belluscura Plc Company Overview 33

5.5.1 Belluscura Plc Pipeline Products & Ongoing Clinical Trials Overview 33

5.6 Braile Biomedica Ltda Company Overview 34

5.6.1 Braile Biomedica Ltda Pipeline Products & Ongoing Clinical Trials Overview 34

5.7 Case Western Reserve University Company Overview 35

5.7.1 Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview 35

5.8 Collplant Biotechnologies Ltd Company Overview 36

5.8.1 Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 36

5.9 enmodes GmbH Company Overview 37

5.9.1 enmodes GmbH Pipeline Products & Ongoing Clinical Trials Overview 37

5.10 Liberate Medical LLC Company Overview 38

5.10.1 Liberate Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 38

5.11 Lung Biotechnology PBC Company Overview 42

5.11.1 Lung Biotechnology PBC Pipeline Products & Ongoing Clinical Trials Overview 42

5.12 Maquet Cardiopulmonary GmbH Company Overview 43

5.12.1 Maquet Cardiopulmonary GmbH Pipeline Products & Ongoing Clinical Trials Overview 43

5.13 McGowan Institute for Regenerative Medicine Company Overview 44

5.13.1 McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview 44

5.14 Michigan Critical Care Consultants Inc Company Overview 49

5.14.1 Michigan Critical Care Consultants Inc Pipeline Products & Ongoing Clinical Trials Overview 49

5.15 Minnesota Health Solutions Corporation Company Overview 50

5.15.1 Minnesota Health Solutions Corporation Pipeline Products & Ongoing Clinical Trials Overview 50

5.16 Miromatrix Medical Inc Company Overview 51

5.16.1 Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 51

5.17 Postgraduate Institute of Medical Education and Research Company Overview 52

5.17.1 Postgraduate Institute of Medical Education and Research Pipeline Products & Ongoing Clinical Trials Overview 52

5.18 Rice University Company Overview 53

5.18.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview 53

5.19 The Charles Stark Draper Laboratory Inc Company Overview 54

5.19.1 The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview 54

5.20 TVS Group Company Overview 55

5.20.1 TVS Group Pipeline Products & Ongoing Clinical Trials Overview 55

5.21 U.S. Ann Arbor Healthcare System Company Overview 56

5.21.1 U.S. Ann Arbor Healthcare System Pipeline Products & Ongoing Clinical Trials Overview 56

5.22 University of Arizona Company Overview 57

5.22.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 57

5.23 University of California Los Angeles Company Overview 58

5.23.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 58

5.24 University of Michigan Company Overview 59

5.24.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 59

5.25 University of Minnesota Company Overview 60

5.25.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 60

5.26 University of Pittsburgh Company Overview 61

5.26.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 61

5.27 Veterans Health Administration Company Overview 63

5.27.1 Veterans Health Administration Pipeline Products & Ongoing Clinical Trials Overview 63

5.28 X-COR Therapeutics Company Overview 65

5.28.1 X-COR Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 65

5.29 Xenios AG Company Overview 66

5.29.1 Xenios AG Pipeline Products & Ongoing Clinical Trials Overview 66

6 Respiratory Assist Devices- Recent Developments 67

6.1 Jun 26, 2024: Luxembourg Voice Technology Revolutionizes Respiratory Health Monitoring 67

6.2 Apr 30, 2024: Liberate Medical Announces PREVENT Study with $6.5M Grant Funding from the US DoD – Enrolls First Patients Globally 67

6.3 Apr 12, 2024: Inogen to Report Q1 Earnings on May 7 68

6.4 Apr 08, 2024: Draper Drives Growth Strategy with Appointment of Carrie George as Chief Financial Officer 68

6.5 Feb 22, 2024: Soleno Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference 69

6.6 Feb 15, 2024: Stephen Agostini Named UCLA’s Vice Chancellor and Chief Financial Officer 69

6.7 Feb 12, 2024: Brett McCone Appointed SVP of Finance at UM Baltimore Washington Medical Center 70

6.8 Feb 08, 2024: Teleflex Announces Fourth Quarter 2023 Earnings Conference Call Information 70

6.9 Nov 14, 2023: Miromatrix Reports Third Quarter 2023 Results 70

6.10 Nov 13, 2023: Inogen Announces Leadership Change with the Appointment of Kevin Smith as President and CEO 71

6.11 Nov 07, 2023: Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results 71

6.12 Nov 05, 2023: Teleflex Reports Third Quarter Financial Results, Full Year 2023 Outlook 73

6.13 Sep 07, 2023: Inogen Names Mike Sergesketter As Interim CFO To Succeed Kristin Caltrider 73

6.14 Aug 16, 2023: Soleno Therapeutics Announces Appointment of Industry Veteran Matthew Pauls, J.D., M.B.A. to Board of Directors 73

6.15 Aug 14, 2023: Miromatrix Medical Reports Second Quarter 2023 Results and Provides Corporate Update 74

6.16 Aug 08, 2023: Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results 75

6.17 Aug 03, 2023: Teleflex Reports Second Quarter Financial Results and Full Year 2023 Outlook 76

7 Appendix 80

7.1 Methodology 80

7.2 About GlobalData 83

7.3 Contact Us 83

7.4 Disclaimer 83

Table

Respiratory Assist Devices – Pipeline Products by Stage of Development 10

Respiratory Assist Devices – Pipeline Products by Segment 11

Respiratory Assist Devices – Pipeline Products by Territory 12

Respiratory Assist Devices – Pipeline Products by Regulatory Path 13

Respiratory Assist Devices – Pipeline Products by Estimated Approval Date 14

Respiratory Assist Devices – Ongoing Clinical Trials 15

Respiratory Assist Devices Companies – Pipeline Products by Stage of Development 16

Respiratory Assist Devices – Pipeline Products by Stage of Development 18

Advanced Respiratory Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 20

Pulmonary Assist Device – Product Status 20

Pulmonary Assist Device – Product Description 20

Airiver Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 21

Airiver Nasal Drug Coated Balloon (DCB) Catheter – Product Status 21

Airiver Nasal Drug Coated Balloon (DCB) Catheter – Product Description 21

Airiver Pulmonary Drug Coated Balloon (DCB) catheter – Product Status 22

Airiver Pulmonary Drug Coated Balloon (DCB) catheter – Product Description 22

Airiver Medical Inc – Ongoing Clinical Trials Overview 23

Airiver Nasal Drug Coated Balloon (DCB) Catheter – Prospective Trial of Paclitaxel-Coated Nasal Balloon for the Treatment of Recurrent Chronic Rhinosinusitis With or Without Nasal Polyps 24

Airiver Pulmonary Drug Coated Balloon (DCB) catheter – Prospective Trial of Paclitaxel-Coated Pulmonary Balloon for the Treatment of Benign Airway Obstruction (OXYGEN-1 Trial) 25

ALung Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 26

Hattler Catheter – Product Status 26

Hattler Catheter – Product Description 26

Next Generation Artificial Lung – Product Status 27

Next Generation Artificial Lung – Product Description 27

ULFED – <1L/min – Product Status 27

ULFED – <1L/min – Product Description 28

ULFED – 250 mL/min – Product Status 28

ULFED – 250 mL/min – Product Description 29

Baxter Healthcare Corp Pipeline Products & Ongoing Clinical Trials Overview 30

PrismaLung+ – Product Status 30

PrismaLung+ – Product Description 30

Baxter Healthcare Corp – Ongoing Clinical Trials Overview 31

PrismaLung+ – A Novel ECCO2R Device as a Lung Protective Measure in Hypercapnic Respiratory Failure: A Prospective Multicenter Trial 32

PrismaLung+ – Measuring the Impact of Extracorporeal Carbon Dioxide Removal Using PrismaLung in Reducing Ventilator Induced Lung Injury in Mechanically Ventilated Patients 32

Belluscura Plc Pipeline Products & Ongoing Clinical Trials Overview 33

Portable Artificial Lung – Product Status 33

Portable Artificial Lung – Product Description 33

Braile Biomedica Ltda Pipeline Products & Ongoing Clinical Trials Overview 34

Artificial Respirator – Product Status 34

Artificial Respirator – Product Description 34

Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview 35

Portable Artificial Lung – Product Status 35

Portable Artificial Lung – Product Description 35

Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 36

3D Bioprinted Lung Transplant – Product Status 36

3D Bioprinted Lung Transplant – Product Description 36

enmodes GmbH Pipeline Products & Ongoing Clinical Trials Overview 37

RAS-Q – Product Status 37

RAS-Q – Product Description 37

Liberate Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 38

SecondBreath – Product Status 38

SecondBreath – Product Description 38

VentFree Respiratory Muscle Stimulator – Product Status 39

VentFree Respiratory Muscle Stimulator – Product Description 39

Liberate Medical LLC – Ongoing Clinical Trials Overview 40

VentFree Respiratory Muscle Stimulator – A Randomized, Sham Controlled, Double-blinded, Multi-center Trial to Evaluate the Efficacy of the VentFree Respiratory Muscle Stimulator to Assist Ventilator Weaning in Critically Ill Patients 41

Lung Biotechnology PBC Pipeline Products & Ongoing Clinical Trials Overview 42

XenoLung – Product Status 42

XenoLung – Product Description 42

Maquet Cardiopulmonary GmbH Pipeline Products & Ongoing Clinical Trials Overview 43

PALP – Product Status 43

PALP – Product Description 43

McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview 44

A,P- modELAS ECCO2R – Product Status 44

A,P- modELAS ECCO2R – Product Description 45

A-ModELAS – Product Status 45

A-ModELAS – Product Description 45

Biohybrid Artificial Lung – Product Status 46

Biohybrid Artificial Lung – Product Description 46

Chronic Artificial Lung – Product Status 46

Chronic Artificial Lung – Product Description 47

Impeller Percutaneous Respiratory Assist Catheter (iPRAC) – Product Status 47

Impeller Percutaneous Respiratory Assist Catheter (iPRAC) – Product Description 47

P-modelas – Product Status 48

P-modelas – Product Description 48

Michigan Critical Care Consultants Inc Pipeline Products & Ongoing Clinical Trials Overview 49

BioLung – Product Status 49

BioLung – Product Description 49

Minnesota Health Solutions Corporation Pipeline Products & Ongoing Clinical Trials Overview 50

Non-Invasive Ventilator Respiratory Interface – Product Status 50

Non-Invasive Ventilator Respiratory Interface – Product Description 50

Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 51

Mirolung – Product Status 51

Mirolung – Product Description 51

Postgraduate Institute of Medical Education and Research Pipeline Products & Ongoing Clinical Trials Overview 52

SMARTS (Smart Mechatronic Artificial Respiratory Therapy System) – COVID-19 – Product Status 52

SMARTS (Smart Mechatronic Artificial Respiratory Therapy System) – COVID-19 – Product Description 52

Rice University Pipeline Products & Ongoing Clinical Trials Overview 53

Respiratory Assist Device – Product Status 53

Respiratory Assist Device – Product Description 53

The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview 54

Silicone-Based Microfluidic Artificial Lung – Product Status 54

Silicone-Based Microfluidic Artificial Lung – Product Description 54

TVS Group Pipeline Products & Ongoing Clinical Trials Overview 55

Sundaram Ventago – Product Status 55

Sundaram Ventago – Product Description 55

U.S. Ann Arbor Healthcare System Pipeline Products & Ongoing Clinical Trials Overview 56

3D-Printed Artificial Lung – Product Status 56

3D-Printed Artificial Lung – Product Description 56

University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 57

HeCOS – Product Status 57

HeCOS – Product Description 57

University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 58

Percutaneous Catheter for Lung Assist Device – Product Status 58

Percutaneous Catheter for Lung Assist Device – Product Description 58

University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 59

M-Lung – Product Status 59

M-Lung – Product Description 59

University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 60

Catheter-Based Intravenous Respirator – Product Status 60

Catheter-Based Intravenous Respirator – Product Description 60

University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 61

P-PAL – Product Status 61

P-PAL – Product Description 61

Paracorporeal Ambulatory Assist Lung – Product Status 62

Paracorporeal Ambulatory Assist Lung – Product Description 62

Veterans Health Administration Pipeline Products & Ongoing Clinical Trials Overview 63

3D Printed Microfluidic Artificial Lung – Product Status 63

3D Printed Microfluidic Artificial Lung – Product Description 63

Artificial Lung – Product Status 64

Artificial Lung – Product Description 64

X-COR Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 65

Extracorporeal CO2 Removal Device – Product Status 65

Extracorporeal CO2 Removal Device – Product Description 65

Xenios AG Pipeline Products & Ongoing Clinical Trials Overview 66

i-lung – Product Status 66

i-lung – Product Description 66

Glossary 82

Figures

Respiratory Assist Devices – Pipeline Products by Stage of Development 10

Respiratory Assist Devices – Pipeline Products by Segment 11

Respiratory Assist Devices – Pipeline Products by Territory 12

Respiratory Assist Devices – Pipeline Products by Regulatory Path 13

Respiratory Assist Devices – Pipeline Products by Estimated Approval Date 14

Respiratory Assist Devices – Ongoing Clinical Trials 15

Frequently asked questions

Respiratory Assist Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

Most Popular
$8,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Respiratory Assist Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Respiratory Assist Devices reports
Medical Devices
New
Global M&A Deals in H1 2026 - Top Themes by…
$495 | August 2026
Medical Devices
New
Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…
$495 | July 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Respiratory Assist Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Respiratory Assist Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more